ArticleActa pharmaceutica Sinica. B2024

Engineered extracellular vesicles efficiently deliver CRISPR-Cas9 ribonucleoprotein (RNP) to inhibit herpes simplex virus1 infection

Yuanda Wan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.